The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
about
Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1Clinical significance of HIV-1 coreceptor usage.Löfgren's syndrome: human leukocyte antigen strongly influences the disease courseGlobal survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.HIV-1 envelope determinants for cell tropism and chemokine receptor use.CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4.Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.Maternal SDF1 3'A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission.Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.Naturally occurring deletional mutation in the C-terminal cytoplasmic tail of CCR5 affects surface trafficking of CCR5.Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolutionLow human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.Genetics and immunopathogenesis of IgA nephropathy.Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication.Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.Polymorphism in RANTES chemokine promoter affects HIV-1 disease progressionCCR2 genotype and disease progression in a treated population of HIV type 1-infected women.CD192 gene variant and susceptibility to cervical cancer: a meta analysisHost factors influencing susceptibility to HIV infection and AIDS progression.Apoptosis in SIV infection.The G protein-coupled receptors: pharmacogenetics and disease.Host genetic determinants of HIV pathogenesis: an immunologic perspectiveGlobal human genetics of HIV-1 infection and China.Multiple roles for chemokines in the pathogenesis of SIV infectionCCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro.A review of the clinical pharmacology of maraviroc. Introduction.Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc.Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein.Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection.Differential cell tropism of feline immunodeficiency virus molecular clones in vivo.CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates.Anti-envelope antibody responses in individuals at high risk of hepatitis C virus who resist infectionThe central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease.Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus.Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleNovel mutations and SNPs identified in CCR2 using a new comprehensive denaturing gradient gel electrophoresis assay.
P2860
Q24310870-EA9BD9F0-B24E-4FD3-91FC-099F5E44106DQ27691426-92A4D80E-A9F5-48F1-A36A-B3037A3C3A12Q28300383-E95DB8FC-294C-41B4-8A7F-F0D787B28BA7Q30328141-61780CC8-E188-4FF8-BDCF-CA8DF5337390Q33637946-0F3C0294-B474-4104-AD9E-CB5A21182DF6Q33654027-1E5185FE-D0C7-4879-9179-DF82224E6C4DQ33783914-702AEDCF-201E-45D2-90E2-412236866482Q33785321-EE889E4A-4505-430F-B19A-760AB402E916Q33805434-7635C0C0-B3E9-4479-BEEE-44622DFCC28DQ33806110-C22E1EE2-B82A-4DFB-B6F7-73C18E5CE6BCQ33835337-A20AADFE-5D75-4EE2-89C6-43B67B0C83F8Q33838860-B95DAE32-1649-45BD-882E-86AE358115ECQ33854213-7F6B7298-CC4A-4EFB-A0F8-82C065DFEDB1Q33883813-5275555C-3CD1-48A6-A6C6-82B02C3879E1Q33961704-BCBE99AD-F331-421E-B5EB-5F9BAF5F1CF6Q34156795-FD7F1D35-9CD1-4210-97AF-905030FAC880Q34339609-F334904E-092E-4E21-AAA7-B6745384084CQ34357979-42061B93-4ECE-4527-B514-58783CDD3162Q34996361-AB64CB98-8AF5-47F2-8D70-C598E4E1EA6DQ35133507-58665E73-3C04-4C95-AC13-90868B7891E4Q35187455-B8ECAEE6-D6BD-47DB-8E89-C789E5265CF7Q35959197-C9CFDA89-00DD-4306-BF3C-D881C74E0E4DQ35995936-F4267328-5851-4B45-B49E-47E2FBAE2236Q36092834-E8B5BDEE-AF71-4F3A-8E89-C0F2732D10E0Q36310854-0AB5AA5A-BD12-441E-BBA4-AA7100C0EAF2Q36329596-F25F0596-2938-4A3E-9753-0CEF86442E5CQ36342033-8CA5EA03-2836-4BC9-B923-47DF88779FA1Q36634172-35FAB335-D742-4B7F-8D2B-82CC03658625Q37058575-213E4378-DD21-43B3-9F22-1B8E5FBA3EB2Q37107480-5D3D5FBA-2554-4B4D-8A54-C2F38EC5CCC8Q37421895-3926D516-6FA2-493E-B803-535F898E2A3DQ38911714-E59BDB5C-583D-4EB6-863B-9B9AF99EF1AFQ39376055-B25CEC3D-49E1-494E-9659-AE28EB2DD9BCQ39549678-FD3DB791-77BD-45A7-A954-6B5DB5987BC6Q39682772-B03925D7-E08F-44F8-8621-0B217EDE65F5Q40471338-4B7B4DE4-A43F-453F-8B92-64B885DC77EDQ41743838-7F48AA05-4817-4862-A76C-9108A9D48B3DQ42474483-7D87D0DF-3D32-489D-9E3F-388BF975F056Q42623165-1476EA76-87FD-443E-9BDD-CDDFEEBC369FQ44153659-BD46466E-F9FD-483C-8052-6424B7AEC7BB
P2860
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@ast
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@en
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@nl
type
label
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@ast
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@en
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@nl
prefLabel
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@ast
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@en
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@nl
P2093
P2860
P356
P1433
P1476
The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression.
@en
P2093
Dayhoff DE
Michael NL
Rohrbaugh AL
Schultz KA
Sheppard HW
P2860
P2888
P304
P356
10.1038/NM1097-1160
P407
P577
1997-10-01T00:00:00Z